Save information for later
Sign Up

Learn About Familial Colorectal Cancer

What is the definition of Familial Colorectal Cancer?
Familial colon cancer is a cluster of colon cancer within a family. Most cases of colon cancer occur sporadically in people with little to no family history of the condition. Approximately 3-5% of colon cancer is considered "hereditary" and is thought to be caused by an inherited predisposition to colon cancer that is passed down through a family in an autosomal dominant or autosomal recessive manner. In some of these families, the underlying genetic cause is not known; however, many of these cases are caused by changes in the APC, MYH, MLH1, MSH2, MSH6, PMS2, EPCAM, PTEN, STK11, SMAD4, BMPR1A, NTHL1, POLE, and POLD1 genes (which are associated with hereditary cancer syndromes). An additional 10-30% of people diagnosed with colon cancer have a significant family history of the condition but have no identifiable genetic change in a gene known to cause a hereditary predisposition to colon cancer. These clusters of colon cancer are likely due to a combination of gene(s) and other shared factors such as environment and lifestyle.
What are the alternative names for Familial Colorectal Cancer?
  • Familial colorectal cancer
  • Colorectal cancer, familial
Who are the top Familial Colorectal Cancer Local Doctors?
Hematology Oncology | Hematology | Oncology
Hematology Oncology | Hematology | Oncology

Northwest Oncology And Hematology

800 Biesterfield Road, Suite 210, Enter Building 5 Next To ER. Take Elevators On The Left Up To 2nd Floor., 
Elk Grove, IL 
 1.4 mi
Accepting New Patients
Offers Telehealth

Steven Kanter is a Hematologist Oncology specialist and a Hematologist in Elk Grove, Illinois. Dr. Kanter and is rated as a Distinguished provider by MediFind in the treatment of Familial Colorectal Cancer. His top areas of expertise are Familial Colorectal Cancer, Lung Cancer, Pleuropulmonary Blastoma, and Paget Disease of the Breast. Dr. Kanter is currently accepting new patients.

Hematology Oncology | Hematology | Oncology
Hematology Oncology | Hematology | Oncology

Northwest Oncology And Hematology

800 Biesterfield Road, Suite 210, Enter Building 5 Next To ER. Take Elevators On The Left Up To 2nd Floor., 
Elk Grove, IL 
 1.4 mi
Accepting New Patients
Offers Telehealth

Erol Yorulmazoglu is a Hematologist Oncology specialist and a Hematologist in Elk Grove, Illinois. Dr. Yorulmazoglu and is rated as a Distinguished provider by MediFind in the treatment of Familial Colorectal Cancer. His top areas of expertise are Lung Cancer, Colorectal Cancer, Pleuropulmonary Blastoma, and Familial Colorectal Cancer. Dr. Yorulmazoglu is currently accepting new patients.

 
 
 
 
Learn about our expert tiers
Learn More
Hematology Oncology | Oncology
Hematology Oncology | Oncology

Ctca Physicians Group Of Illinois, Llc.

9300 Waukegan Rd, 
Morton Grove, IL 
 9.3 mi
Accepting New Patients
Offers Telehealth

Edward Kaplan is a Hematologist Oncology specialist and an Oncologist in Morton Grove, Illinois. Dr. Kaplan and is rated as a Distinguished provider by MediFind in the treatment of Familial Colorectal Cancer. His top areas of expertise are Colorectal Cancer, Familial Colorectal Cancer, Breast Cancer, and Paget Disease of the Breast. Dr. Kaplan is currently accepting new patients.

What are the latest Familial Colorectal Cancer Clinical Trials?
Developing a Couple-Based Mindfulness Intervention for Metastatic Colorectal Cancer: Qualitative Phase

Summary: The overall objective of this study is to develop a novel couple-based mindfulness intervention aimed at reducing distress in patients with metastatic colorectal cancer (mCRC) and their partners.

Match to trials
Find the right clinical trials for you in under a minute
Get started
Implementation of a Tumor Response Assessment Program Integrating Shared Medical Decision Making Into the Organ Preservation Strategy for Rectal Cancer Patients: Phase III Randomized - Multicenter

Summary: The adoption of total mesorectal excision (TME) has standardized rectal cancer surgery and improved oncological outcomes. In locally advanced rectal cancer, neoadjuvant radio chemotherapy (NACRT) has further improved oncological benefit. Although these strategies result in good 5-year disease-free survival rates, they are associated with significant morbidity, in particular permanent long-term bow...

Who are the sources who wrote this article ?

Published Date: May 02, 2022
Published By: Genetic and Rare Diseases Informnation Center